Skip to Content

Bethaprim Pediatric Side Effects

Generic Name: sulfamethoxazole / trimethoprim

Note: This page contains information about the side effects of sulfamethoxazole / trimethoprim. Some of the dosage forms included on this document may not apply to the brand name Bethaprim Pediatric.

For the Consumer

Applies to sulfamethoxazole / trimethoprim: oral suspension, oral tablet

Other dosage forms:

In addition to its needed effects, some unwanted effects may be caused by sulfamethoxazole / trimethoprim. In the event that any of these side effects do occur, they may require medical attention.

Major Side Effects

You should check with your doctor immediately if any of these side effects occur when taking sulfamethoxazole / trimethoprim:

  • Abdominal or stomach pain
  • black, tarry stools
  • blistering, peeling, or loosening of the skin
  • changes in skin color
  • chest pain
  • chills
  • cough or hoarseness
  • dark urine
  • diarrhea
  • dizziness
  • fever with or without chills
  • general feeling of tiredness or weakness
  • headache
  • itching
  • joint or muscle pain
  • light-colored stools
  • loss of appetite
  • lower back or side pain
  • nausea
  • pain, tenderness, or swelling of the foot or leg
  • painful or difficult urination
  • pale skin
  • rash
  • red skin lesions, often with a purple center
  • red, irritated eyes
  • shortness of breath
  • sore throat
  • sores, ulcers, or white spots in the mouth or on the lips
  • swollen or painful glands
  • tightness in the chest
  • unpleasant breath odor
  • unusual bleeding or bruising
  • vomiting of blood
  • wheezing
  • yellow eyes or skin
Incidence not known:
  • Abdominal or stomach tenderness
  • back, leg, or stomach pains
  • bleeding gums
  • blindness or vision changes
  • blisters, hives, or itching
  • bloating
  • blood in the urine or stools
  • bluish-colored lips, fingernails, or palms
  • burning, crawling, itching, numbness, painful, prickling, "pins and needles", or tingling feelings
  • burning of the face or mouth
  • chest pain
  • cloudy urine
  • confusion
  • constipation
  • continuing ringing or buzzing or other unexplained noise in the ears
  • convulsions
  • cracks in the skin
  • decreased frequency or amount of urine
  • diarrhea, watery and severe, which may also be bloody
  • difficulty with breathing
  • difficulty with swallowing
  • fainting spells
  • general body swelling
  • general feeling of discomfort or illness
  • hair loss
  • hearing loss
  • hives
  • increased thirst
  • indigestion
  • irregular heartbeat
  • large, flat, blue, or purplish patches in the skin
  • large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
  • loss of heat from the body
  • muscle or joint pain
  • nosebleeds
  • not able to pass urine
  • numbness or tingling in the hands, feet, or lips
  • pain or burning while urinating
  • pinpoint red spots on the skin
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • raised red swellings on the skin, the buttocks, legs, or ankles
  • redness of the white part of the eyes
  • redness, swelling, or soreness of the tongue
  • sores, ulcers, or white spots on the lips or in the mouth
  • soreness of the muscles
  • stiff neck or back
  • swelling of the face, hands, legs, and feet
  • unsteadiness, trembling, or other problems with muscle control or coordination
  • unusual weight loss
  • weakness in the hands or feet
  • weakness or heaviness of the legs
  • weight gain

Minor Side Effects

Some of the side effects that can occur with sulfamethoxazole / trimethoprim may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:

More common:
  • Passing of gas
Incidence not known:
  • Discouragement
  • feeling of constant movement of self or surroundings
  • feeling sad or empty
  • increased sensitivity of the skin to sunlight
  • irritability
  • lack of feeling or emotion
  • loss of interest or pleasure
  • nervousness
  • redness or other discoloration of the skin
  • seeing, hearing, or feeling things that are not there
  • sensation of spinning
  • severe sunburn
  • trouble concentrating
  • trouble sleeping
  • uncaring
  • weight loss

For Healthcare Professionals

Applies to sulfamethoxazole / trimethoprim: intravenous solution, oral suspension, oral tablet


The most common side effects have included nausea, vomiting, anorexia, rash, and urticaria. Side effects generally are more common and more severe in patients with AIDS.

The most frequently reported serious adverse reactions in elderly patients have included severe skin reactions, generalized bone marrow suppression, a specific decrease in platelets (with or without purpura), and hyperkalemia.

Sulfonamides have rarely been associated with fatal reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, fulminant hepatic necrosis, agranulocytosis, aplastic anemia, other blood dyscrasias, and hypersensitivity of the respiratory tract.[Ref]

Adverse reactions to sulfamethoxazole-trimethoprim occur in 50% to 100% of patients with AIDS, compared to approximately 14% in those without AIDS receiving treatment for Pneumocystis jiroveci pneumonia. Up to 57% of AIDS patients treated with sulfamethoxazole-trimethoprim require a change in therapy due to adverse effects.[Ref]


Dermatologic side effects were usually due to hypersensitivity to the sulfamethoxazole component.

A few cases of acute febrile neutrophilic dermatosis (Sweet's syndrome), characterized by abrupt onset of painful erythematous plaques or nodules and a fever greater than 38 degrees Celsius, have been reported.[Ref]

Rare (less than 0.1%): Acute febrile neutrophilic dermatosis (Sweet's syndrome), acute patchy exanthematous pustulosis (at least 1 case)
Frequency not reported: Mild erythroderma, severe exfoliative dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, exfoliative dermatitis, generalized skin eruptions, photosensitivity, phototoxicity, pruritus, urticaria, rash[Ref]


Frequency not reported: Nausea, vomiting/emesis, diarrhea, stomatitis, glossitis, abdominal pain, anorexia, pseudomembranous colitis, Clostridium difficile associated diarrhea, pancreatitis[Ref]


Frequency not reported: Anaphylaxis, allergic myocarditis, angioedema, Henoch-Schonlein purpura, serum sickness-like syndrome, generalized allergic reactions, fixed drug eruption, hypersensitivity reactions (including cholestatic jaundice, interstitial nephritis, liver failure, renal failure, pancytopenia, hypotension, pulmonary edema, elevated serum transaminases)[Ref]

A case of fixed drug eruption due to polysensitivity (sulfamethoxazole-trimethoprim and tenoxicam) and reactivation of previous (10 years earlier) sulfamethoxazole-trimethoprim-associated fixed drug eruption lesions has been reported.

Hypersensitivity reactions may be more likely in patients with HIV infection, with opportunistic infections, or patients who are slow acetylators.

Hypotension, pulmonary edema, and elevated serum transaminases have been reported following sulfamethoxazole-trimethoprim administration to HIV-infected patients.

Hypersensitivity reactions in some cases have included cholestatic jaundice, interstitial nephritis, liver failure, renal failure, and pancytopenia.

A 48-year-old male developed liver failure, renal failure requiring hemodialysis, and pancytopenia requiring blood transfusions after 10 days of treatment with sulfamethoxazole-trimethoprim for pyelonephritis. This was believed to be a hypersensitivity reaction. He was a slow acetylator phenotype and had concurrently taken acetaminophen and diclofenac; the acetaminophen may have contributed to the reaction by inhibiting NAT2.[Ref]


Frequency not reported: Agranulocytosis, aplastic anemia, thrombocytopenia, leukopenia, neutropenia, hemolytic anemia, megaloblastic anemia, hypoprothrombinemia, methemoglobinemia, eosinophilia
Postmarketing reports: Thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura[Ref]

Because trimethoprim inhibits a step in folate synthesis, patients that are likely to have preexisting folate deficiencies (e.g., alcoholics, malnourished patients, patients on phenytoin or antifolate metabolites, and those with chronic hemolysis) are at risk of developing megaloblastic anemia during sulfamethoxazole-trimethoprim therapy. Folate replenishment reverses this effect.

Methemoglobinemia occurred twice in an HIV-infected patient who inadvertently received sulfamethoxazole-trimethoprim a second time after the first course was discontinued due to development of methemoglobinemia.[Ref]

Nervous system

Rare (less than 0.1%): Higher-level gait disorder (at least 1 case)
Frequency not reported: Aseptic meningitis, convulsions, peripheral neuritis, ataxia, vertigo, tinnitus, headache, dizziness, tremors, lightheadedness, coma, seizures, multifocal myoclonus, bilateral asterixis, exacerbation of posthypoxic action myoclonus[Ref]

Exacerbation of posthypoxic action myoclonus occurred in a patient with non-Hodgkin's lymphoma who was receiving high-dose intravenous sulfamethoxazole-trimethoprim (115 mg/kg/day) for suspected Pneumocystis pneumonia.

HIV-infected patients receiving high-dose intravenous sulfamethoxazole-trimethoprim appear to have a greater incidence of tremors. The tremors generally appear several days after initiating therapy and resolve several days after discontinuation or dose reduction.

An 82-year-old male developed higher-level gait disorder on day 37 of treatment, 2 days after his dosage was doubled to sulfamethoxazole 320 mg-trimethoprim 1600 mg orally twice a day. During this time, the patient also had nocturnal delirium. Sulfamethoxazole-trimethoprim was discontinued on day 48 and the patient's gait returned to normal and his nocturnal delirium resolved by day 51.[Ref]


Frequency not reported: Renal failure, interstitial nephritis, elevated BUN and serum creatinine, toxic nephrosis with oliguria and anuria, tubular necrosis, crystalluria, aggravation of renal disease, azotemia, hyperkalemic renal tubular acidosis, overestimations of normal creatinine values[Ref]

Trimethoprim inhibits renal tubular creatinine secretion, which can result in a significant decrease in creatinine clearance. These changes appear to be completely reversible upon discontinuation of therapy. Sulfamethoxazole may cause sulfa crystalluria, especially during low urine output states.

Interstitial nephritis and tubular necrosis may be due to hypersensitivity.

The propylene glycol vehicle in intravenous sulfamethoxazole-trimethoprim and lorazepam has also been implicated in the development of acute tubular necrosis in a patient.

Hyperkalemia has occurred with both standard and high-dose therapy. Reported cases have resolved upon discontinuation of the drug, although a few have required treatment with sodium polystyrene sulfonate. Up to 20% of patients with AIDS who are given sulfamethoxazole-trimethoprim for Pneumocystis pneumonia develop mild hyperkalemia.

Sulfamethoxazole-trimethoprim may interfere with creatinine determinations by the Jaffe alkaline picrate assay, resulting in overestimations of normal values.[Ref]


Frequency not reported: Hepatitis (including cholestatic jaundice, hepatic necrosis), elevated serum transaminase, elevated bilirubin, elevated liver function tests, fulminant hepatic failure, hepatic and/or cholestatic lesions, hepatitis with simultaneous pancreatitis, hepatorenal failure, cholestatic liver disease with ductopenia[Ref]

Cholestatic hepatitis associated with sulfamethoxazole-trimethoprim therapy may present with other signs of hypersensitivity, such as rash, fever, and eosinophilia. Biopsy findings in patients with sulfamethoxazole-trimethoprim-associated cholestatic hepatitis have included hepatic necrosis, hepatocyte degeneration, hepatic granuloma, centrilobular congestion, and inflammatory infiltrates.

A 34-year-old female developed pancreatitis and hepatitis after inadvertently receiving sulfamethoxazole-trimethoprim for treatment of a urinary tract infection several years after experiencing a previous episode of sulfamethoxazole-trimethoprim-associated hepatitis.[Ref]


Hyperkalemia may occur as a result of the blocking of sodium channels by trimethoprim, which causes a reduction of potassium excretion in the distal tubule.

High doses of intravenous sulfamethoxazole-trimethoprim appear to be associated with a greater incidence of metabolic acidosis.

Sulfonamides may induce hypoglycemia. However, the establishment of a causal relationship has been difficult in most cases of suspected sulfa-induced hypoglycemia because many of the affected patients had AIDS, may have had another viral infection, or were on other medications.

Hypouricemia has been associated with high-dose therapy.[Ref]

Rare (less than 0.1%): Hypoglycemia
Frequency not reported: Hyperkalemia, metabolic acidosis, hyponatremia, hypouricemia[Ref]


Frequency not reported: Sepsis-like syndrome (hypotension, fever, rash, and pulmonary infiltrates), weakness, fatigue, drug fever, chills, facial edema[Ref]


Frequency not reported: Hallucinations, depression, apathy, nervousness, insomnia, irritability, confusion, disorientation, catatonia, nocturnal delirium, exacerbation of panic attacks, acute psychoses[Ref]


Isolated cases of rhabdomyolysis have been reported, primarily in patients with AIDS.[Ref]

Rare (less than 0.1%): Rhabdomyolysis
Frequency not reported: Arthralgia, myalgia, periarteritis nodosa, systemic lupus erythematosus[Ref]


Frequency not reported: Cough, shortness of breath, pulmonary infiltrates[Ref]

Hypersensitivity reactions of the respiratory tract associated with sulfonamides have included cough, shortness of breath, and pulmonary infiltrates.[Ref]


Diuresis has been reported rarely in patients receiving sulfonamides.

Significant reductions in male sperm counts have been reported after 1 month of therapy.[Ref]

Rare (less than 0.1%): Diuresis
Frequency not reported: Decreased sperm counts[Ref]


Local reaction, pain, and slight irritation on intravenous administration have been reported infrequently.[Ref]

Rare (less than 0.1%): Local reaction, pain, slight irritation[Ref]


Rare (less than 0.1%): Thrombophlebitis
Postmarketing reports: QT prolongation resulting in ventricular tachycardia and torsade de pointes


Rare (less than 0.1%): Goiter[Ref]

Endocrine side effects associated with sulfonamides have rarely included goiter production.[Ref]


Frequency not reported: Conjunctival and scleral injection


1. "Product Information. Bactrim (trimethoprim-sulfamethoxazole)." Roche Laboratories, Nutley, NJ.

2. Green H, Paul M, Vidal L, Leibovici L "Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials." Mayo Clin Proc 82 (2007): 1052-9

3. Martin GJ, Paparello SF, Decker CF "A severe systemic reaction to trimethoprim-sulfamethoxazole in a patient infected with the human immunodeficiency virus." Clin Infect Dis 16 (1993): 175-6

4. Cockerill F, Edson R "Trimethoprim-sulfamethoxazole." Mayo Clin Proc 62 (1987): 921-9

5. Wanat KA, Anadkat MJ, Klekotka PA "Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole." J Am Acad Dermatol 60 (2009): 589-94

6. Chierakul W, Anunnatsiri S, Short JM, et al. "Two Randomized Controlled Trials of Ceftazidime Alone versus Ceftazidime in Combination with Trimethoprim-Sulfamethoxazole for the Treatment of Severe Melioidosis." Clin Infect Dis 41 (2005): 1105-13

7. Carr A, Penny R, Cooper DA "Eficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients." AIDS 7 (1993): 65-71

8. Marinac JS, Stanford JF "A severe hypersensitive reaction to trimethoprim-sulfamethoxazole in a patient infected with human immunodeficiency virus." Clin Infect Dis 16 (1993): 178-9

9. Lee I, Turner M, Lee CC "Acute patchy exanthematous pustulosis caused by sulfamethoxazole-trimethoprim." J Am Acad Dermatol 63 (2010): e41-3

10. Tuteja S, Alloway RR, Johnson JA, Gaber AO "The effect of gut metabolism on tacrolimus bioavailability in renaltransplant recipients." Transplantation 71 (2001): 1303-7

11. Bernstein L "Adverse reaction to trimethoprim-sulfamethoxazole, with particular reference to long-term therapy." Can Med Assoc J 112 (1975): s96-8

12. Finland M "Combinations of antimicrobial drugs: trimethoprim-sulfamethoxazole." N Engl J Med 291 (1974): 624-7

13. Walker DC, Cohen PR "Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced sweet's syndrome." J Am Acad Dermatol 34 (1996): 918-23

14. Roudier C, Caumes E, Rogeaux O, Bricaire F, Gentilini M "Adverse cutaneous reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome and pneumocystis carinii pneumonia." Arch Dermatol 130 (1994): 1383-6

15. Azfar RS, Cohn J, Schaffer A, Kim EJ "Trimethoprim sulfamethoxazole-induced sweet syndrome." Arch Dermatol 145 (2009): 215-6

16. Heer M, Altorfer J, Burger H, Walti M "Bullous esophageal lesions due to co-trimoxazole: an immune-mediated process?" Gastroenterology 88 (1985): 1954-7

17. Sugarman B "Trimethoprim-sulfamethoxazole, pseudomembranous colitis, and spinal cord injury." South Med J 78 (1985): 711-3

18. Ruff D, Jaffe J, London R, Candio J "Pseudomembranous colitis following low dose trimethoprim-sulfamethoxazole." J Urol 134 (1985): 1218-9

19. Thibert J, Gasparini A, Diaz-Mitoma F, Conway B, Cameron DW "Tolerance of oral trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis of Pneumocystis carinii pneumonia (PCP)." Int Conf AIDS 9 (1993): 368

20. Gordin F, Gibert C, Schmidt ME "Clostridium difficile colitis associated with trimethoprim-sulfamethoxazole given as prophylaxis for pneumocystis carinii pneumonia." Am J Med 96 (1994): 94-5

21. Arnold P, Guglielmo J, Hollander H "Severe hypersensitivity reaction upon rechallenge with trimethoprim-sulfamethoxazole in a patient with AIDS." Drug Intell Clin Pharm 22 (1988): 43-5

22. Moreno JN, Poblete RB, Maggio C, Gagnon S, Fischl MA "Rapid oral desensitization for sulfonamides in patients with the acquired immunodeficiency syndrome." Ann Allergy Asthma Immunol 74 (1995): 140-6

23. Lehmann DF, Liu A, Newman N, Blair DC "The association of opportunistic infections with the occurrence of trimethoprim/sulfamethoxazole hypersensitivity in patients infected with human immunodeficiency virus." J Clin Pharmacol 39 (1999): 533-7

24. Milligan KS, Phillips DL "Perioral Numbness Associated with Intravenous Pentamidine Administration (January)." Ann Pharmacother 41 (2007): 153-6

25. Ransohoff D, Jacobs G "Terminal hepatic failure following a small dose of sulfamethoxazole-trimethoprim." Gastroenterology 80 (1981): 816-9

26. Whittington R "Toxic epidermal necrolysis and co-trimoxazole." Lancet 2 (1989): 574

27. Berg PA, Daniel PT "Co-trimoxazole-induced hepatic injury: an analysis of cases with hypersensitivity-like reactions." Infection 15 (1987): s259-64

28. Iborra C, Jouan M, Baril L, Katlama C, Bricaire F, Caumes E "High dose trimethoprim sulfamethoxazole therapy with corticosteroids in previously intolerant patients with AIDS associated Pneumocystis carinii pneumonia." Arch Dermatol 135 (1999): 350-1

29. Johnson M, Goodwin D, Shands J "Trimethoprim-sulfamethoxazole anaphylactoid reactions in patients with AIDS: case reports and literature review." Pharmacotherapy 10 (1990): 413-16

30. Moore RD, Fortgang I, Keruly J, Chaisson RE "Adverse events from drug therapy for human immunodeficiency virus disease." Am J Med 101 (1996): 34-40

31. Ozkaya E "Oral mucosal fixed drug eruption: characteristics and differential diagnosis." J Am Acad Dermatol 69 (2013): e51-8

32. Hughes BR, Holt PJ, Marks R "Trimethoprim associated fixed drug eruption." Br J Dermatol 116 (1987): 241-2

33. Kalanadhabhatta V, Muppidi D, Sahni H, Robles A, Kramer M "Successful oral desensitization to trimethoprim-sulfamethoxazole in acquired immune deficiency syndrome." Ann Allergy Asthma Immunol 77 (1996): 394-400

34. Rubin R, Swartz M "Trimethoprim-sulfamethoxazole." N Engl J Med 303 (1980): 426-32

35. Roujeau JC, Kelly JP, Naldi L, et al. "Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis." N Engl J Med 333 (1995): 1600-7

36. Windecker R, Steffen J, Cascorbi I, Thurmann PA "Co-trimoxazole-induced liver and renal failure." Eur J Clin Pharmacol 56 (2000): 191-3

37. Ramakrishnan K, Scheid DC "Diagnosis and management of acute pyelonephritis in adults." Am Fam Physician 71 (2005): 933-42

38. Stevenson D, Christie D, Haas J "Hepatic injury in a child caused by trimethoprim-sulfamethoxazole." Pediatrics 61 (1978): 864-6

39. Ozkaya-Bayazit E "Independent lesions of fixed drug eruption caused by trimethoprim-sulfamethoxazole and tenoxicam in the same patient: a rare case of polysensitivity." J Am Acad Dermatol 51(2 Suppl) (2004): S102-4

40. Ulstad D, Ampel N, Shon B, Galgiani JN, Cutcher AB "Reaction after re-exposure to trimethoprim-sulfamethoxazole." Chest 95 (1989): 937-8

41. Kelly W, Dooley D, Lattuada C, Smith C "A severe, unusual reaction to trimethoprim-sulfamethoxazole in patients infected with human immunodeficiency virus." Clin Infect Dis 14 (1992): 1034-9

42. Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A "Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy." Clin Infect Dis 45 (2007): 548-55

43. Smith E, Light J, Filo R, Yum M "Interstitial nephritis caused by trimethoprim-sulfamethoxazole in renal transplant recipients." JAMA 244 (1980): 360-1

44. Holdcroft C, Ellison R "Trimethoprim-sulfamethoxazole reaction simulating pneumocystis carinii pneumonia." AIDS 5 (1991): 1029-42

45. Gluckstein D, Ruskin J "Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ." Clin Infect Dis 20 (1995): 849-53

46. Vanderven AJM, Koopmans PP, Vree TB, Vandermeer JWM "Drug intolerance in HIV disease." J Antimicrob Chemother 34 (1994): 1-5

47. Alonso MD, Marcos C, Davila I, et al "Hypersensitivity to trimethoprim." Allergy 47 (1992): 340-2

48. Chan M, Beale D, Moorhead J "Acute megaloblastosis due to cotrimoxazole." Br J Clin Pract 34 (1980): 87-8

49. Barak S, Shaked Y, Bar A, Samra Y "Drug-induced post-surgical hemorrhage resulting from trimethoprim-sulphamethoxazole." Int J Oral Maxillofac Surg 18 (1989): 206-7

50. Betkowski AS, Lubin A "Sulfamethoxazole-related antiplatelet antibody." Blood 82 (1993): 1683

51. Hawkins T, Carter JM, Romeril KR, Jackson SR, Green GJ "Severe trimethoprim induced neutropenia and thrombocytopenia." N Z Med J 106 (1993): 251-2

52. Chertow GM, Seifter JL, Christiansen CL, Odonnell WJ "Trimethoprim-sulfamethoxazole and hypouricemia." Clin Nephrol 46 (1996): 193-8

53. Cook DE, Ponte CD "Suspected trimethoprim sulfamethoxazole induced hypoprothrombinemia." J Fam Pract 39 (1994): 589-91

54. Jaffe HS, Abrams DI, Ammannn AJ, Lewis BJ, Golden JA "Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men." Lancet 2 (1983): 1109-11

55. Damergis J, Stoker J, Abadie J "Methemoglobinemia after sulfamethoxazole and trimethoprim therapy." JAMA 249 (1983): 590-1

56. Keisu M, Wiholm B, Palmblad J "Trimethoprim-sulphamethoxazole-associated blood dyscrasias: ten years' experience of the Swedish Spontaneous Reporting System." J Intern Med 228 (1990): 353-60

57. Koirala J "Trimethoprim-sulfamethoxazole--induced methemoglobinemia in an HIV-infected patient." Mayo Clin Proc 79 (2004): 829-30

58. Matzdorff AC "Drug-induced immune thrombocytopenia." N Engl J Med 357 (2007): 1870; author reply 1871

59. Liu L, Seward S, Crumpacker C "Intravenous trimethoprim-sulfamethoxazole and ataxia." Ann Intern Med 104 (1986): 448

60. Gregor JC, Zilli CA, Gotlib IH "Acute psychosis associated with oral trimethoprim-sulfamethoxazole therapy." Can J Psychiatry 38 (1993): 56-8

61. Rudy BJ, Rutstein R "Aseptic meningitis from trimethoprim-sulfamethoxazole in an HIV-infected adolescent." Pediatr Emerg Care 13 (1997): 216-7

62. Holland GN "Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management." Am J Ophthalmol 137 (2004): 1-17

63. Jundt F, Lempert T, Dorken B, Pezzutto A "Trimethoprim-Sulfamethoxazole Exacerbates Posthypoxic Action Myoclonus in a Patient with Suspicion of Pneumocystis jiroveci Infection." Infection 32 (2004): 176-8

64. Jurado R, Carpenter SL, Rimland D "Trimethoprim-sulfamethoxarole-induced meningitis in patients with HIV infection." Am J Med Sci 312 (1996): 27-9

65. Whyte CA, Shivdat-Nanhoe R, Kramer P "A Case of Amoxicillin-Induced Meningitis." Clin Infect Dis 46 (2008): 642

66. Patterson RG, Couchenour RL "Trimethoprim-sulfamethoxazole-induced tremor in an immunocompetent patient." Pharmacotherapy 19 (1999): 1456-8

67. McCue J, Zandt J "Acute psychoses associated with the use of ciprofloxacin and trimethoprim-sulfamethoxazole." Am J Med 90 (1991): 528-9

68. Jurado R, Carpenter SL, Rimland D "Case reports: trimethoprim-sulfamethoxazole-induced meningitis in patients with HIV infection." Am J Med Sci 312 (1996): 27-9

69. Dakin LE "Probable trimethoprim/sulfamethoxazole-induced higher-level gait disorder and nocturnal delirium in an elderly man." Ann Pharmacother 43 (2009): 129-33

70. Joffe A, Farley J, Linden D, Goldsand G "Trimethoprim-sulfamethoxazole-associated aseptic meningitis: case reports and review of the literature." Am J Med 87 (1989): 332-8

71. Saxw T "Severe depression from TMP-SMX." Drug Intell Clin Pharm 22 (1988): 267

72. Slavik RS, Rybak MJ, Lerner SA "Trimethoprim/sulfamethoxazole-induced tremor in a patient with AIDS." Ann Pharmacother 32 (1998): 189-92

73. Carlson J, Wiholm BE "Trimethoprim associated aseptic meningitis." Scand J Infect Dis 19 (1987): 687-91

74. Pashankar D, Mcardle M, Robinson A "Co-trimoxazole induced aseptic meningitis." Arch Dis Child 73 (1995): 257-8

75. Borucki MJ, Matzke DS, Pollard R "Tremor induced by trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome (AIDS)." Ann Intern Med 109 (1988): 77-8

76. Ahn Y-H, Goldman JM "Trimethoprim-sulfamethoxazole and hyponatremia." Ann Intern Med 103 (1985): 161-2

77. Myre SA, McCann J, First MR, Cluxton RJ "Effect of trimethoprim on serum creatinine in healthy and chronic renal failure volunteers." Ther Drug Monit 9 (1987): 161-5

78. Cryst C, Hammar S "Acute granulomatous interstitial nephritis due to co-trimoxazole." Am J Nephrol 8 (1988): 483-8

79. Perazella MA "Acute renal failure in HIV-infected patients: A brief review of common causes." Am J Med Sci 319 (2000): 385-91

80. Greenberg S, Reiser IW, Chou SY "Hyperkalemia with high-dose trimethoprim-sulfamethoxazole therapy." Am J Kidney Dis 22 (1993): 603-6

81. Perazella MA, Mahnensmith RL "Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose." Clin Nephrol 46 (1996): 187-92

82. Schlanger LE, Kleyman TR, Ling BN "K+-sparing diuretic actions of trimethoprim - inhibition of na+ channels in a6 distal nephron cells." Kidney Int 45 (1994): 1070-6

83. Sheehan MT, Wen SF "Hyperkalemic renal tubular acidosis induced by trimethoprim/sulfamethoxazole in an AIDS patient." Clin Nephrol 50 (1998): 188-93

84. Roling J, Schmid H, Fischereder M, Draenert R, Goebel FD "HIV-Associated Renal Diseases and Highly Active Antiretroviral Therapy-Induced Nephropathy." Clin Infect Dis 42 (2006): 1488-95

85. Alappan R, Perazella MA, Buller GK "Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole." Ann Intern Med 124 (1996): 316-20

86. Bugge JF "Severe hyperkalaemia induced by trimethoprim in combination with an angiotensin-converting enzyme inhibitor in a patient with transplanted lungs." J Intern Med 240 (1996): 249-51

87. Rudra T, Webb D, Evans A "Acute tubular necrosis following co-trimoxazole therapy." Nephron 53 (1989): 85-6

88. Smith GW, Cohen SB "Hyperkalaemia and non-oliguric renal failure associated with trimethoprim." Br Med J 308 (1994): 454

89. Perlmutter EP, Sweeney D, Herskovits G, Kleiner M "Severe hyperkalemia in a geriatric patient receiving standard doses of trimethoprim-sulfamethoxazole." Am J Med Sci 311 (1996): 84-5

90. Hayman M, Seidl EC, Ali M, Malik K "Acute tubular necrosis associated with propylene glycol from concomitant administration of intravenous lorazepam and trimethoprim-sulfamethoxazole." Pharmacotherapy 23 (2003): 1190-4

91. Choi MJ, Fernandez PC, Patnaik A, Coupaye-Gerard B, D'Andrea D, Szerlip H, Kleyman TR "Brief report: trimethoprim-induced hyperkalemia in a patient with AIDS." N Engl J Med 328 (1993): 703-6

92. Kastrup J, Petersen P, Bartram R, Hansen JM "The effect of trimethoprim on serum creatinine." Br J Urol 57 (1985): 265-8

93. Simma B, Meister B, Deutsch J, Sperl W, Fend F, Ofner D, Margreiter R, Vogel W "Fulminant hepatic failure in a child as a potential adverse effect of trimethoprim-sulphamethoxazole." Eur J Pediatr 154 (1995): 530-3

94. Alberti-Flor JJ, Hernandez ME, Ferrer JP, Howell S, Jeffers L "Fulminant liver failure and pancreatitis associated with the use of sulfamethoxazole-trimethoprim." Am J Gastroenterol 84 (1989): 1577-9

95. Horak J, Mertl L, Hrabal P "Severe liver injuries due to sulfamethoxazole-trimethoprim and sulfamethoxydiazine." Hepatogastroenterology 31 (1984): 199-200

96. Yao F, Behling CA, Saab S, Li SJ, Hart M, Lyche KD "Trimethoprim-sulfamethoxazole-induced vanishing bile duct syndrome." Am J Gastroenterol 92 (1997): 167-9

97. Thies PW, Dull WL "Trimethoprim-sulfamethoxazole-induced cholestatis hepatitis." Arch Intern Med 144 (1984): 1691-2

98. Altraif I, Lilly L, Wanless IR, Heathcote J "Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamethoxazole." Am J Gastroenterol 89 (1994): 1230-4

99. Kowdley K, Keeffe E, Fawaz K "Prolonged cholestasis due to trimethoprim-sulfamethoxazole." Gastroenterology 102 (1992): 2148-50

100. Schattner A, Rimon E, Green L, Coslovsky R, Bentwich Z "Hypoglycemia induced by co-trimoxazole in AIDS." BMJ 297 (1988): 742

101. Brett AS, Shaw SV "Simultaneous pancreatitis and hepatitis associated with trimethoprim-sulfamethoxazole." Am J Gastroenterol 94 (1999): 267-8

102. Cario E, Runzi M, Becker EW, Groger G, Ali A, Rehbehn K, Goebell H, Layer P "Cholestatic hepatitis induced by trimethoprim plus sulphamethoxazole: clinical and immunological evidence of on allergic genesis." Dtsch Med Wochenschr 121 (1996): 129-32

103. "Prevent-ERR: sulfamethoxazole and trimethoprim-induced hyperkalemia." ISMP Medication Safety Alert! 13(Dec 4) (2008): 3

104. Perazella MA, Buller GK "Hyperkalemia and trimethoprim-sulfamethoxazole - Reply." Am J Kidney Dis 29 (1997): 962-5

105. Porras MC, Lecumberri JN, Castrillon JL "Trimethoprim/sulfamethoxazole and metabolic acidosis in HIV-infected patients." Ann Pharmacother 32 (1998): 185-9

106. Hartman NR, Yarchoan R, Pluda JM "Pharmacokinetics of 2', 3'-dideoxyadenosine and 2', 3' dideoxyinosine in patients with severe human immunodeficiency virus infection." Clin Pharmacol Ther 47 (1990): 647-54

107. Lee AJ, Maddix DS "Trimethoprin/sulfamethoxazole-induced hypoglycemia in a patient with acute renal failure." Ann Pharmacother 31 (1997): 727-32

108. Rosini JM, Martinez E, Jain R "Severe hypoglycemia associated with use of trimethoprim/sulfamethoxazole in a patient with chronic renal insufficiency." Ann Pharmacother 42 (2008): 593-4

109. Ellison DH "Hyperkalemia and trimethoprim-sulfamethoxazole - Discussion." Am J Kidney Dis 29 (1997): 959-62

110. Iaccheri B, Fiore T, Papadaki T, et al. "Adverse drug reactions to treatments for ocular toxoplasmosis: A retrospective chart review." Clin Ther 30 (2008): 2069-74

111. Vangerpen JA "Tremor caused by trimethoprim-sulfamethoxazole in a patient with AIDS." Neurology 48 (1997): 537-8

112. Murdia A, Mathur V, Kothari LK, Singh KP "Sulpha-trimethoprim combination and male fertility." Lancet 2 (1978): 375-6

113. Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation. 5th ed." Baltimore, MD: Williams & Wilkins (1998):

Not all side effects for Bethaprim Pediatric may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.